These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 1654986

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Epidermal growth factor receptor in non-small cell cancer of the lung].
    Díez M, Maestro ML, Torres A, Hernando F, Ortega MD, García-Asenjo JA, Picardo A, Mugüerza JM, Sánchez-Pernaute A, Balibrea JL.
    Arch Bronconeumol; 1994; 30(6):282-6. PubMed ID: 8087386
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis.
    Pfeiffer P, Nexø E, Bentzen SM, Clausen PP, Andersen K, Rose C.
    Br J Cancer; 1998 Jul; 78(1):96-9. PubMed ID: 9662257
    [Abstract] [Full Text] [Related]

  • 6. Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer.
    Veale D, Kerr N, Gibson GJ, Harris AL.
    Cancer Res; 1989 Mar 01; 49(5):1313-7. PubMed ID: 2537147
    [Abstract] [Full Text] [Related]

  • 7. Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections.
    Pfeiffer P, Clausen PP, Andersen K, Rose C.
    Br J Cancer; 1996 Jul 01; 74(1):86-91. PubMed ID: 8679464
    [Abstract] [Full Text] [Related]

  • 8. DNA analysis by flow cytometry in nonsmall cell lung cancer: relationship to epidermal growth factor receptor, histology, tumour stage and survival.
    Dazzi H, Thatcher N, Hasleton PS, Swindell R.
    Respir Med; 1990 May 01; 84(3):217-23. PubMed ID: 2171051
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.
    Hilbe W, Dirnhofer S, Oberwasserlechner F, Eisterer W, Ammann K, Schmid T, Hilbe G, Thaler J, Wöll E.
    J Clin Pathol; 2003 Oct 01; 56(10):736-41. PubMed ID: 14514775
    [Abstract] [Full Text] [Related]

  • 10. Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue.
    Dittadi R, Donisi PM, Brazzale A, Cappellozza L, Bruscagnin G, Gion M.
    Br J Cancer; 1993 Jan 01; 67(1):7-9. PubMed ID: 8427782
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor receptors in non-small cell lung cancer.
    Veale D, Ashcroft T, Marsh C, Gibson GJ, Harris AL.
    Br J Cancer; 1987 May 01; 55(5):513-6. PubMed ID: 3038157
    [Abstract] [Full Text] [Related]

  • 12. Urokinase receptors in lung cancer and normal lung.
    Veale D, Needham G, Harris AL.
    Anticancer Res; 1990 May 01; 10(2A):417-21. PubMed ID: 2161199
    [Abstract] [Full Text] [Related]

  • 13. Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance.
    Nicholson S, Sainsbury JR, Needham GK, Chambers P, Farndon JR, Harris AL.
    Int J Cancer; 1988 Jul 15; 42(1):36-41. PubMed ID: 3391706
    [Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study.
    Koenders PG, Beex LV, Kienhuis CB, Kloppenborg PW, Benraad TJ.
    Breast Cancer Res Treat; 1993 Jul 15; 25(1):21-7. PubMed ID: 8518406
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue.
    Koenders PG, Peters WH, Wobbes T, Beex LV, Nagengast FM, Benraad TJ.
    Br J Cancer; 1992 Feb 15; 65(2):189-92. PubMed ID: 1739615
    [Abstract] [Full Text] [Related]

  • 16. Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival.
    Dazzi H, Hasleton PS, Thatcher N, Barnes DM, Wilkes S, Swindell R, Lawson RA.
    Br J Cancer; 1989 May 15; 59(5):746-9. PubMed ID: 2544220
    [Abstract] [Full Text] [Related]

  • 17. Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors.
    Reubi JC, Waser B, Sheppard M, Macaulay V.
    Int J Cancer; 1990 Feb 15; 45(2):269-74. PubMed ID: 1968052
    [Abstract] [Full Text] [Related]

  • 18. Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas.
    Rachwal WJ, Bongiorno PF, Orringer MB, Whyte RI, Ethier SP, Beer DG.
    Br J Cancer; 1995 Jul 15; 72(1):56-64. PubMed ID: 7599067
    [Abstract] [Full Text] [Related]

  • 19. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer.
    Kashihara M, Azuma K, Kawahara A, Basaki Y, Hattori S, Yanagawa T, Terazaki Y, Takamori S, Shirouzu K, Aizawa H, Nakano K, Kage M, Kuwano M, Ono M.
    J Thorac Oncol; 2009 Sep 15; 4(9):1066-74. PubMed ID: 19648825
    [Abstract] [Full Text] [Related]

  • 20. In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor.
    Damstrup L, Rude Voldborg B, Spang-Thomsen M, Brünner N, Skovgaard Poulsen H.
    Br J Cancer; 1998 Sep 15; 78(5):631-40. PubMed ID: 9744504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.